Press release
BK virus infections Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharma
"BK virus infections Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the BK virus infections Market.
The BK virus infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the BK virus infections Pipeline Report: https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel BK virus infections treatment therapies with a considerable amount of success over the years.
• BK virus infections companies working in the treatment market are Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharmaceuticals, Vera Therapeutics, AlloVir, and others, are developing therapies for the BK virus infections treatment
• Emerging BK virus infections therapies in the different phases of clinical trials are- BK virus antiviral therapy, AIC 468, AntiBKV antibody, Brincidofovir, MAU868, ALVR 105, and others are expected to have a significant impact on the BK virus infections market in the coming years.
• In August 2025, AiCuris Anti-infective Cures AG has shared initial clinical data from its ongoing first-in-human Phase 1 trial of AIC468, a novel antiviral antisense oligonucleotide being developed to treat BK virus (BKV) infections in kidney transplant patients. Interim findings, presented at the World Transplant Congress on August 4, 2025, in San Francisco, highlight the pharmacokinetic (PK) profile of AIC468 based on data from healthy volunteer participants in the trial.
• In July 2025, Memo Therapeutics AG (MTx), a late-stage biotech company focused on developing breakthrough therapies for viral infections and cancer, has announced results from its Phase II clinical trial of potravitug-a potent human monoclonal antibody targeting BK polyomavirus (BKPyV). The SAFE KIDNEY II trial, a randomized, double-blind, placebo-controlled study, assessed the efficacy of potravitug in treating BKPyV infection in kidney transplant recipients (KTR). A total of 95 patients were enrolled across 22 sites in the U.S. (NCT05769582) to evaluate the antibody's ability to reduce BKPyV levels in both blood and kidney tissue.
• In November 2024, AiCuris Anti-infective Cures has launched a first-in-human Phase I clinical trial for AIC468, an antisense oligonucleotide developed to treat BK virus (BKV) infections in kidney transplant patients. The study is designed to evaluate the safety, tolerability, and pharmacokinetics of AIC468 in healthy participants. This double-blind, randomized, placebo-controlled trial will enroll 72 healthy volunteers between the ages of 18 and 64 and will be conducted in Germany.
BK virus infections Overview
BK virus (BKV) is a common virus that infects humans, usually during childhood. It belongs to the polyomavirus family and remains latent (inactive) in the body after initial infection. Most people do not experience any symptoms or health problems from BK virus infection.
Get a Free Sample PDF Report to know more about BK virus infections Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging BK virus infections Drugs Under Different Phases of Clinical Development Include:
• BK virus antiviral therapy: Orthogon Therapeutics
• AIC 468: AiCuris
• AntiBKV antibody: Memo Therapeutics
• Brincidofovir: SymBio Pharmaceuticals
• MAU868: Vera Therapeutics
• ALVR 105: AlloVir
BK virus infections Route of Administration
BK virus infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
BK virus infections Molecule Type
BK virus infections Products have been categorized under various Molecule types, such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
BK virus infections Pipeline Therapeutics Assessment
• BK virus infections Assessment by Product Type
• BK virus infections By Stage and Product Type
• BK virus infections Assessment by Route of Administration
• BK virus infections By Stage and Route of Administration
• BK virus infections Assessment by Molecule Type
• BK virus infections by Stage and Molecule Type
DelveInsight's BK virus infections Report covers around 10+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further BK virus infections product details are provided in the report. Download the BK virus infections pipeline report to learn more about the emerging BK virus infections therapies
https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the BK virus infections Therapeutics Market include:
Key companies developing therapies for BK virus infections are - AlloVir, Amplyx Pharmaceuticals, Memo therapeutics, Hybridize therapeutics, SLVaxiGenInc, and others.
BK virus infections Pipeline Analysis:
The BK virus infections pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of BK virus infections with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for BK virus infections Treatment.
• BK virus infections key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• BK virus infections Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the BK virus infections market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about BK virus infections drugs and therapies
https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
BK virus infections Pipeline Market Drivers
• Increase in the number of patients requiring kidney transplant worldwide, technological and medical advancements, guidelines supporting early detection and prompt diagnosis are some of the important factors that are fueling the BK virus infections Market.
BK virus infections Pipeline Market Barriers
• However, due to the lack of effective treatment options against BK virus infection, biology of BKPyV is not completely understood. side effects associated with the current treatment options and other factors are creating obstacles in the BK virus infections Market growth.
Scope of BK virus infections Pipeline Drug Insight
• Coverage: Global
• Key BK virus infections Companies: Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharmaceuticals, Vera Therapeutics, AlloVir, and others
• Key BK virus infections Therapies: BK virus antiviral therapy, AIC 468, AntiBKV antibody, Brincidofovir, MAU868, ALVR 105, and others
• BK virus infections Therapeutic Assessment: BK virus infections current marketed and BK virus infections emerging therapies
• BK virus infections Market Dynamics: BK virus infections market drivers and BK virus infections market barriers
Request for Sample PDF Report for BK virus infections Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. BK virus infections Report Introduction
2. BK virus infections Executive Summary
3. BK virus infections Overview
4. BK virus infections- Analytical Perspective In-depth Commercial Assessment
5. BK virus infections Pipeline Therapeutics
6. BK virus infections Late Stage Products (Phase II/III)
7. BK virus infections Mid Stage Products (Phase II)
8. BK virus infections Early Stage Products (Phase I)
9. BK virus infections Preclinical Stage Products
10. BK virus infections Therapeutics Assessment
11. BK virus infections Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. BK virus infections Key Companies
14. BK virus infections Key Products
15. BK virus infections Unmet Needs
16 . BK virus infections Market Drivers and Barriers
17. BK virus infections Future Perspectives and Conclusion
18. BK virus infections Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
BK virus infections Market https://www.delveinsight.com/report-store/bk-virus-bkv-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'BK virus infections Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
BK virus infections Epidemiology https://www.delveinsight.com/report-store/bk-virus-bkv-infection-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'BK virus infections Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
• Neuroendoscopy Market: https://www.delveinsight.com/report-store/neuroendoscopy-market
• Nosocomial Infections Market: https://www.delveinsight.com/report-store/nosocomial-infections-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Dry Eye Disease Market: https://www.delveinsight.com/report-store/dry-eye-disease-market-insights
• Nonalcoholic Steatohepatitis Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BK virus infections Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharma here
News-ID: 4137615 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
